Liver failure is among the most complex conditions nursing students will manage in acute care, and it demands a strong command of assessment, scoring tools, and intervention priorities. Whether acute or chronic, hepatic failure disrupts nearly every body system — coagulation, fluid balance, neurological function, renal perfusion, and nutritional status all deteriorate as the liver loses its synthetic and detoxification capacity.
This reference covers both acute and chronic liver failure from the nursing perspective: pathophysiology, Child-Pugh and MELD scoring, clinical manifestations, hepatic encephalopathy grading, priority nursing assessments, interventions, and when to escalate. Pair it with the nursing lab values cheat sheet and the electrolyte imbalances reference — liver failure labs are meaningless without context.
| Quick reference | Detail |
|---|---|
| Definition | Loss of hepatic function severe enough to cause coagulopathy and altered mentation |
| Acute liver failure | Rapid onset (<26 weeks) in a patient with no prior liver disease |
| Chronic liver failure | End-stage cirrhosis with progressive decompensation over months to years |
| Key scoring tools | Child-Pugh (cirrhosis severity), MELD/MELD-Na (transplant prioritization) |
| Most dangerous complication | Hepatic encephalopathy — grades 3–4 require ICU transfer |
| Priority nursing assessment | Neurological status, coagulation (INR/PT), fluid balance, ammonia levels |
Acute versus chronic liver failure
The distinction between acute and chronic liver failure is clinically critical because the causes, trajectory, and nursing priorities differ. Acute liver failure (ALF) is a medical emergency with rapid deterioration. Chronic liver failure develops over years as cirrhosis progresses through stages of decompensation.
| Feature | Acute liver failure | Chronic liver failure (cirrhosis) |
|---|---|---|
| Onset | Days to weeks (<26 weeks from first liver injury) | Months to years of progressive fibrosis |
| Prior liver disease | None — previously healthy liver | Yes — underlying cirrhosis from alcohol, hepatitis, NAFLD, or other causes |
| Most common causes (US) | Acetaminophen toxicity (~46%), viral hepatitis, drug reactions, autoimmune hepatitis | Alcohol-related liver disease, hepatitis C, non-alcoholic steatohepatitis (NASH) |
| Hallmark triad | Coagulopathy (INR ≥1.5) + encephalopathy + no prior liver disease | Portal hypertension + hepatocellular dysfunction + decompensation events |
| Cerebral edema risk | High — leading cause of death in ALF | Rare in chronic failure |
| Ascites at presentation | Uncommon | Common — often the first sign of decompensation |
| Reversibility | Potentially reversible (acetaminophen-induced ALF has ~65% spontaneous survival with N-acetylcysteine) | Irreversible without transplant — management is supportive |
| Transplant timing | Emergent (status 1A listing) | Elective — prioritized by MELD score |
| Nursing setting | ICU — continuous monitoring mandatory | Med-surg, step-down, or ICU depending on decompensation severity |
| Mortality without transplant | ~40–50% in non-acetaminophen causes | Variable — Child-Pugh C: ~55% one-year mortality |
For NCLEX and clinical practice, remember this distinction: acute liver failure is an emergency where the liver shuts down fast in a previously healthy patient. Chronic liver failure is a slow decline where the liver has been compensating for years until it can no longer keep up — decompensated cirrhosis.
Pathophysiology: how the liver fails
The liver performs over 500 metabolic functions. When hepatocytes are destroyed faster than they can regenerate, cascading failures develop across multiple systems.
In acute liver failure
Massive hepatocyte necrosis occurs over days to weeks. The triggers vary — acetaminophen overwhelms glutathione-mediated detoxification, viral hepatitis causes immune-mediated destruction, and drug reactions trigger idiosyncratic hepatocyte death. The result is the same: rapid loss of synthetic function (coagulopathy), impaired detoxification (encephalopathy from ammonia accumulation), and loss of metabolic capacity (hypoglycemia, lactic acidosis). Cerebral edema from ammonia-driven astrocyte swelling is the leading cause of death in ALF.
In chronic liver failure (cirrhosis)
Chronic injury activates hepatic stellate cells, which deposit collagen and produce fibrosis. Over years, fibrous bands replace normal hepatic architecture, creating regenerative nodules. This structural distortion does two things:
- Raises portal pressure. Fibrosis compresses the portal venous system, creating portal hypertension (portal pressure >10 mmHg). This drives the major complications: varices, ascites, splenomegaly, and portosystemic shunting.
- Reduces functional hepatocyte mass. Synthetic capacity drops — albumin falls, coagulation factors decrease (elevated INR), and bilirubin clearance fails (jaundice).
Portosystemic shunting is particularly important for nursing assessment: blood bypasses the liver through collateral vessels, meaning ammonia and other toxins reach the brain unfiltered. This is the mechanism behind hepatic encephalopathy.
The progression from compensated to decompensated cirrhosis is marked by the first appearance of ascites, variceal bleeding, encephalopathy, or jaundice. Once decompensation occurs, median survival drops from >12 years (compensated) to approximately 2 years without transplant.
Staging and scoring
Two scoring systems dominate hepatic assessment. Both appear on NCLEX and are used daily in clinical practice.
Child-Pugh score
The Child-Pugh classification stratifies the severity of chronic liver disease (cirrhosis) using three lab values and two clinical findings. Each parameter receives 1 to 3 points.
| Parameter | 1 point | 2 points | 3 points |
|---|---|---|---|
| Total bilirubin | <2 mg/dL | 2–3 mg/dL | >3 mg/dL |
| Serum albumin | >3.5 g/dL | 2.8–3.5 g/dL | <2.8 g/dL |
| INR | <1.7 | 1.7–2.2 | >2.2 |
| Ascites | None | Mild (controlled with diuretics) | Moderate to severe (refractory) |
| Hepatic encephalopathy | None | Grade 1–2 | Grade 3–4 |
Classification:
- Class A (5–6 points): Well-compensated cirrhosis. One-year survival ~100%. Patients often manage as outpatients.
- Class B (7–9 points): Significant functional compromise. One-year survival ~80%. Transplant evaluation should be initiated.
- Class C (10–15 points): Decompensated cirrhosis. One-year survival ~45%. Active transplant listing or palliative care discussion is appropriate.
Nursing relevance: the Child-Pugh score helps you anticipate the patient’s clinical trajectory. A Class C patient admitted for a GI bleed is in a fundamentally different risk category than a Class A patient with the same presentation.
MELD and MELD-Na scores
The Model for End-Stage Liver Disease (MELD) score is used primarily for transplant allocation in the United States. Unlike Child-Pugh, MELD uses only objective laboratory data — no clinical assessment variables.
MELD formula components:
- Serum bilirubin (liver function)
- INR (coagulation/synthetic function)
- Serum creatinine (renal function — capped at 4.0 mg/dL)
MELD-Na adds serum sodium, which improves mortality prediction because hyponatremia is strongly associated with poor outcomes in cirrhosis.
Score interpretation:
| MELD score | 3-month mortality | Clinical implication |
|---|---|---|
| <10 | ~2% | Stable — routine monitoring |
| 10–19 | ~6% | Increased risk — closer follow-up |
| 20–29 | ~20% | Significant risk — active transplant listing |
| 30–39 | ~50–70% | High urgency — prioritized for transplant |
| ≥40 | >70% | Critical — highest transplant priority |
The MELD score ranges from 6 to 40. Higher scores mean greater urgency for transplantation. Scores are recalculated at intervals determined by the score itself — patients with MELD ≥25 are recalculated every 7 days, while those with MELD <10 are recalculated annually.
Clinical manifestations
Liver failure produces a constellation of findings across multiple organ systems. Recognizing these patterns is essential for nursing assessment.
Jaundice and pruritus
Jaundice becomes clinically apparent when serum bilirubin exceeds 2.5–3.0 mg/dL. The yellow discoloration appears first in the sclera, then in the skin and mucous membranes. Unconjugated (indirect) bilirubin accumulates when hepatocytes cannot conjugate bilirubin, while conjugated (direct) bilirubin rises when bile excretion is obstructed.
Pruritus (itching) results from bile salt deposition in the skin and can be severe enough to disrupt sleep and cause excoriation injuries. Nursing interventions include cool compresses, antihistamines, cholestyramine for bile salt binding, and keeping nails trimmed to prevent skin breakdown.
Ascites
Ascites — fluid accumulation in the peritoneal cavity — results from portal hypertension, hypoalbuminemia (reduced oncotic pressure), and sodium/water retention driven by the renin-angiotensin-aldosterone system (RAAS). It is often the first sign of decompensated cirrhosis.
Nursing assessment includes daily abdominal girth measurements taken at the same location each time, daily weights, strict intake and output monitoring, and tracking of serum albumin and sodium. Management involves sodium restriction (typically <2 g/day), diuretics (spironolactone first-line, often combined with furosemide), and therapeutic paracentesis for large-volume or tense ascites. Monitor closely for spontaneous bacterial peritonitis (SBP) — fever, abdominal pain, worsening encephalopathy, or rising WBC in a patient with ascites should prompt immediate diagnostic paracentesis.
Coagulopathy
The liver synthesizes most clotting factors (I, II, V, VII, IX, X, XI, XII, XIII), protein C, protein S, and antithrombin. In liver failure, coagulopathy manifests as elevated INR/PT, easy bruising, prolonged bleeding from venipuncture sites, and increased risk of GI hemorrhage — especially from esophageal or gastric varices.
Key nursing actions: monitor INR and platelet count trending, hold pressure on venipuncture sites for an extended period, assess for signs of bleeding (melena, hematemesis, hematuria, petechiae), and minimize invasive procedures when possible. Vitamin K may be administered, but it is only effective if the liver has enough functional capacity to use it. Fresh frozen plasma (FFP) or cryoprecipitate may be needed for active bleeding or before procedures.
Review the nursing lab values cheat sheet for coagulation panel normal ranges and clinical significance.
Hepatorenal syndrome
Hepatorenal syndrome (HRS) is renal failure secondary to severe liver disease, occurring without intrinsic kidney pathology. It develops because extreme splanchnic vasodilation (from portal hypertension and nitric oxide excess) reduces effective circulating volume, triggering intense renal vasoconstriction.
Two types exist:
- Type 1 HRS: Rapid decline in renal function (creatinine doubling to >2.5 mg/dL within 2 weeks). Median survival without treatment is approximately 2 weeks. This is a medical emergency.
- Type 2 HRS: Gradual, moderate renal impairment. Associated with refractory ascites. Median survival approximately 6 months.
Nursing assessment: monitor urine output hourly (oliguria <500 mL/day is an early warning), trending serum creatinine and BUN, and urine sodium (<10 mEq/L in HRS). The definitive treatment is liver transplantation. Bridge therapies include albumin infusions combined with vasoconstrictors (terlipressin, norepinephrine, or midodrine plus octreotide).
Portal hypertension and varices
Portal hypertension (portal venous pressure >10 mmHg) forces blood through collateral pathways, creating varices — dilated, thin-walled veins most commonly in the esophagus and stomach. Variceal hemorrhage is a life-threatening emergency with a mortality rate of 15–20% per bleeding episode.
Nursing priorities: monitor for signs of GI bleeding (hematemesis — bright red or coffee-ground emesis, melena, tachycardia, hypotension), maintain two large-bore IV lines in any patient with known varices, and anticipate emergent endoscopy. Non-selective beta-blockers (propranolol, nadolol) are used prophylactically to reduce portal pressure. The Glasgow Coma Scale is a useful adjunct for monitoring patients with variceal bleeding who may also develop encephalopathy.
Hepatic encephalopathy
Hepatic encephalopathy (HE) is a reversible neuropsychiatric syndrome caused by accumulation of neurotoxins — primarily ammonia — that the failing liver cannot clear. It is the complication most directly affected by nursing assessment and intervention.
Pathophysiology of HE
Colonic bacteria metabolize dietary protein and produce ammonia. In a healthy liver, ammonia is converted to urea via the urea cycle and excreted by the kidneys. In liver failure or portosystemic shunting, ammonia bypasses hepatic metabolism and reaches the brain, where astrocytes convert it to glutamine. Glutamine is osmotically active, causing astrocyte swelling, cerebral edema, increased intracranial pressure, oxidative stress, and disruption of neurotransmitter signaling.
West Haven criteria (grading)
The West Haven classification is the standard grading system for hepatic encephalopathy severity:
| Grade | Level of consciousness | Clinical findings | Nursing implications |
|---|---|---|---|
| Covert (minimal) | Normal on routine exam | Abnormal psychometric testing only — impaired attention, working memory, reaction time | May be missed without formal testing. Assess driving safety. Patient education on precipitants. |
| Grade 1 | Mildly impaired awareness | Shortened attention span, euphoria or anxiety, difficulty with simple arithmetic, sleep-wake reversal | Assess orientation frequently. Family may notice personality changes before staff. Fall precautions. |
| Grade 2 | Lethargy, disorientation | Disoriented to time, inappropriate behavior, asterixis (flapping tremor), slurred speech | Reorient frequently. Check for asterixis at each assessment (have patient extend wrists). Aspiration precautions. Lactulose therapy initiation. |
| Grade 3 | Somnolence to semi-stupor | Disoriented to place and person, bizarre behavior, marked confusion, responsive to verbal stimuli but incomprehensible speech | ICU transfer if not already there. Continuous monitoring. Airway management — gag reflex may be diminished. Hold oral medications until swallowing assessed. |
| Grade 4 | Coma | Unresponsive or responsive only to painful stimuli. Loss of protective reflexes. | Intubation for airway protection. Continuous ICP monitoring if cerebral edema suspected. Full ICU care with hemodynamic support. |
Covert HE (minimal and grade 1) is often grouped together in current guidelines. It is clinically significant because it impairs driving ability and quality of life, even though the patient appears grossly normal.
Common precipitants
Identifying and correcting precipitating factors is the single most important step in managing HE. Memorize this list:
- GI bleeding — blood in the gut is a massive protein load that bacteria convert to ammonia
- Infection/sepsis — especially spontaneous bacterial peritonitis (SBP)
- Constipation — prolonged colonic transit increases ammonia absorption
- Dehydration and electrolyte imbalances — hypokalemia and metabolic alkalosis increase ammonia diffusion across the blood-brain barrier
- Dietary protein excess — large protein meals increase ammonia production
- Sedatives and opioids — benzodiazepines, opioids, and other CNS depressants worsen encephalopathy
- Renal failure — reduced ammonia excretion
- Hyponatremia — worsens cerebral edema
- Post-TIPS procedure — transjugular intrahepatic portosystemic shunt increases shunting, bypassing the liver
For more on electrolyte disturbances that precipitate HE, see the electrolyte imbalances reference.
Pharmacological management
Lactulose is first-line treatment. It is a non-absorbable disaccharide that:
- Acts as an osmotic laxative, increasing stool frequency and reducing colonic transit time
- Acidifies the colonic environment (pH drops to ~5), converting ammonia (NH3) to ammonium (NH4+), which is trapped in the lumen and excreted
- Reduces ammonia-producing bacterial populations
Dosing: 20–30 g (30–45 mL) orally 2–4 times daily, titrated to achieve 2–3 soft stools per day. For acute episodes, lactulose enemas (300 mL in 700 mL water) can be given rectally when the patient cannot take oral medications.
Nursing considerations for lactulose: monitor stool frequency and consistency closely. Excessive dosing causes diarrhea, dehydration, and hyponatremia — which paradoxically worsens encephalopathy. The therapeutic target is 2–3 soft stools daily. Educate patients that the medication should produce loose stools; this is the intended effect.
Rifaximin (550 mg twice daily) is a non-absorbable antibiotic used as adjunctive therapy, particularly for prevention of recurrent HE episodes. It reduces ammonia-producing gut bacteria with minimal systemic absorption and side effects. It is typically added when lactulose alone is insufficient or when the patient experiences recurrent HE episodes despite lactulose adherence.
Medications to avoid in liver failure patients:
- Benzodiazepines and opioids (worsen encephalopathy — use with extreme caution if required)
- Acetaminophen (hepatotoxic — maximum 2 g/day in cirrhosis patients, avoided entirely in acute liver failure)
- NSAIDs (increase bleeding risk, impair renal perfusion, and promote sodium retention)
- Metformin (risk of lactic acidosis with hepatic impairment)
- Statins at high doses (hepatotoxicity risk)
Nursing assessment
A systematic assessment approach is essential because liver failure affects virtually every organ system. Organize your assessment around these priorities:
Neurological assessment
- Mental status: Orientation to person, place, time, and situation. Use the Glasgow Coma Scale for objective scoring. Serial assessments are more valuable than single data points — trending changes in mentation is how you catch encephalopathy early.
- Asterixis check: Ask the patient to extend both arms with wrists dorsiflexed and fingers spread for 30 seconds. Involuntary flapping movements indicate grade 2+ encephalopathy. Document whether asterixis is present, absent, or unable to assess (uncooperative or comatose patient).
- Sleep-wake cycle: Reversal of the normal sleep pattern (sleeping during the day, awake at night) is an early sign of HE, often preceding overt confusion.
- Pupil response: In advanced HE with cerebral edema, watch for unilateral pupil dilation — this indicates transtentorial herniation and requires immediate intervention.
Integumentary assessment
- Jaundice: Assess sclera, skin, and mucous membranes. Grade progression from scleral icterus alone to generalized jaundice.
- Spider angiomata: Small, red, spider-like vascular lesions on the face, neck, upper chest, and arms. Result from hyperestrogenism due to impaired hepatic estrogen metabolism.
- Palmar erythema: Redness of the thenar and hypothenar eminences bilaterally.
- Bruising and petechiae: Indicate coagulopathy. Document size, location, and progression.
- Skin integrity: Pruritus causes scratching, leading to excoriation and infection risk. Assess for skin breakdown, particularly in patients with edema.
Fluid and hemodynamic assessment
- Daily weights at the same time, same scale, same clothing — weight is the most reliable indicator of fluid status changes.
- Abdominal girth measured at the umbilicus with the patient supine — mark the measurement site with a skin marker for consistency.
- Strict intake and output including all IV fluids, oral intake, urine output, paracentesis drainage, and estimated stool volume.
- Peripheral edema assessment and grading (1+ through 4+).
- Blood pressure and heart rate trending — watch for hypotension and tachycardia indicating hemorrhage or third-spacing.
Laboratory monitoring
Key labs to monitor and their significance in liver failure:
| Lab value | What it tells you | Concerning trend |
|---|---|---|
| INR/PT | Synthetic function — clotting factor production | Rising INR = worsening synthetic function |
| Serum albumin | Synthetic function — protein production | Falling albumin = poor prognosis, worsening edema |
| Total/direct bilirubin | Conjugation and excretion capacity | Rising bilirubin = worsening hepatocyte function |
| Ammonia level | Detoxification capacity | Rising ammonia = encephalopathy risk (but levels do not always correlate with HE grade) |
| BUN/creatinine | Renal function | Rising creatinine with low urine sodium = hepatorenal syndrome |
| Serum sodium | Dilutional status | Hyponatremia (<130 mEq/L) worsens cerebral edema and HE |
| Platelet count | Splenic sequestration, bone marrow suppression | Thrombocytopenia = increased bleeding risk |
| Serum glucose | Metabolic function | Hypoglycemia in ALF = massive hepatocyte loss, poor prognostic sign |
| Lactate | Tissue perfusion and hepatic clearance | Rising lactate = poor hepatic clearance or tissue hypoperfusion |
Cross-reference these values with the full nursing lab values cheat sheet for normal ranges and additional context.
Nursing interventions
Organize interventions by priority. In liver failure, the most immediately dangerous issues are bleeding, encephalopathy, and infection.
Airway and safety
- Fall precautions for all patients with any grade of HE. Confusion and impaired coordination increase fall risk substantially.
- Aspiration precautions for grade 2+ encephalopathy — elevate the head of the bed 30–45 degrees, assess swallowing before oral medications or meals, and consider NPO status for grade 3–4.
- Seizure precautions in acute liver failure — cerebral edema increases seizure risk. Padded side rails, suction at bedside, supplemental oxygen readily available.
- Restraint avoidance — confused patients with coagulopathy are at high risk for restraint injuries. Use alternative safety measures: bed alarm, 1:1 sitter, low bed position.
Fluid and electrolyte management
- Sodium restriction (typically <2 g/day) for patients with ascites — educate patients and monitor dietary intake.
- Fluid restriction if serum sodium drops below 125 mEq/L — free water restriction helps correct dilutional hyponatremia.
- Diuretic therapy monitoring: Spironolactone (100–400 mg/day) is first-line for ascites; furosemide (40–160 mg/day) is added if response is inadequate. Monitor potassium closely — spironolactone is potassium-sparing while furosemide is potassium-wasting. Target weight loss: 0.5 kg/day without peripheral edema, 1.0 kg/day with peripheral edema.
- Paracentesis care: For large-volume paracentesis (>5 L), albumin replacement (6–8 g per liter removed) is given to prevent post-paracentesis circulatory dysfunction. Monitor vitals during and after the procedure. Assess the site for persistent leakage.
For a deeper review of electrolyte management principles, see the electrolyte imbalances reference.
Nutrition
Malnutrition is present in 20–50% of patients with cirrhosis and directly worsens outcomes. Outdated guidance restricted protein in HE patients — current evidence-based guidelines recommend:
- Protein: 1.2–1.5 g/kg/day. Protein restriction is no longer recommended for HE management. Adequate protein intake is necessary to prevent muscle wasting (sarcopenia), which itself worsens encephalopathy because skeletal muscle is an alternative site for ammonia metabolism.
- Calories: 25–35 kcal/kg/day to meet metabolic demands.
- Branched-chain amino acids (BCAAs): May be supplemented in patients intolerant of standard protein sources.
- Small, frequent meals with a late-evening snack to reduce overnight fasting, which accelerates catabolism in cirrhosis patients.
- Thiamine and folate supplementation, particularly in alcohol-related liver disease — deficiency is common and contributes to neurological symptoms.
Collaborate with the dietitian for all liver failure patients. Nutritional status is a modifiable factor that directly impacts survival.
Infection prevention and monitoring
Patients with liver failure are immunocompromised. Impaired hepatic reticuloendothelial function, reduced complement and opsonin production, and translocation of gut bacteria across a compromised intestinal barrier all increase infection risk.
- Monitor temperature at every assessment — fever in a cirrhosis patient with ascites is SBP until proven otherwise.
- Diagnostic paracentesis should be performed for any patient with ascites who develops fever, abdominal pain, worsening encephalopathy, or unexplained clinical deterioration. SBP is diagnosed when ascitic fluid shows >250 polymorphonuclear cells/mm³.
- Meticulous line care and hand hygiene — central line-associated bloodstream infections carry high mortality in this population.
- Antibiotic prophylaxis with norfloxacin or trimethoprim-sulfamethoxazole may be indicated for patients with a history of SBP or those with low-protein ascitic fluid (<1.5 g/dL).
Medication safety
The liver metabolizes the majority of medications. In liver failure, drug clearance is impaired, leading to drug accumulation and toxicity. Key nursing actions:
- Review all medications for hepatotoxicity and dose adjustments. Consult pharmacy for any drug with hepatic metabolism.
- Avoid or minimize hepatotoxic medications: acetaminophen (limit to 2 g/day max in compensated cirrhosis; avoid in ALF), NSAIDs, high-dose statins, methotrexate, and amiodarone.
- Sedatives require extreme caution. Benzodiazepines have prolonged half-lives in liver failure and precipitate encephalopathy. If sedation is absolutely necessary, use reduced doses of short-acting agents (oxazepam or lorazepam are preferred because they undergo glucuronidation rather than oxidative hepatic metabolism).
- Opioid dose reduction — morphine and most opioids have prolonged clearance. If analgesia is needed, hydromorphone at reduced doses with extended intervals is generally preferred.
- Lactulose adherence — this is the single most important medication for HE prevention. Ensure patients understand the target stool frequency (2–3 soft stools daily) and that stopping the medication will likely trigger an encephalopathy episode.
Complications and when to escalate
Timely recognition of deterioration saves lives in liver failure. Know these escalation triggers:
| Complication | Warning signs | Escalation action |
|---|---|---|
| Variceal hemorrhage | Hematemesis, melena, tachycardia, dropping blood pressure, rising heart rate | Activate rapid response. Two large-bore IVs. Type and crossmatch. Emergent GI consult for endoscopy. Octreotide drip. |
| Grade 3–4 encephalopathy | Somnolence progressing to unresponsiveness, loss of gag reflex, posturing | ICU transfer. Airway assessment — intubation if unable to protect airway. Rectal lactulose if unable to take oral. |
| Hepatorenal syndrome | Urine output <0.5 mL/kg/hr for 6+ hours, creatinine rising despite adequate volume status, urine sodium <10 mEq/L | Nephrology and hepatology consult. Albumin infusion with vasopressors. Transplant evaluation. |
| Spontaneous bacterial peritonitis | Fever, abdominal pain/tenderness, worsening confusion in patient with ascites | Immediate diagnostic paracentesis. Empiric IV cefotaxime (or ceftriaxone) while awaiting culture results. |
| Cerebral edema (ALF) | Hypertension with bradycardia (Cushing response), pupil changes, decerebrate posturing | Neurosurgery consult. ICP monitor placement. Mannitol or hypertonic saline. Head of bed elevation to 30°. Avoid stimulation. |
| Hypoglycemia | Blood glucose <70 mg/dL, diaphoresis, altered mentation, seizures | Dextrose bolus (25 g D50 IV). Continuous dextrose infusion (D10). Frequent glucose monitoring (every 1–2 hours). |
| Acute-on-chronic liver failure | Rapid deterioration in a previously stable cirrhosis patient — often triggered by infection, bleeding, or alcohol relapse | Full workup for precipitant. Organ failure assessment. Consider ICU-level care. Transplant center notification. |
The ABG interpretation guide is essential for managing the complex acid-base disturbances seen in liver failure patients, who often present with respiratory alkalosis (from central hyperventilation) combined with metabolic acidosis (from lactic acid accumulation and renal dysfunction).
Patient education
Before discharge, ensure the patient and family understand:
- Medication adherence: Lactulose must be taken consistently. Stopping it is the most common cause of readmission for HE. Explain the target stool frequency and that diarrhea beyond 3–4 stools per day means the dose needs adjustment.
- Sodium restriction: Teach label reading. Most processed foods exceed the 2 g/day sodium limit in a single serving.
- Alcohol cessation: Absolute and permanent, regardless of etiology. Even non-alcohol-related cirrhosis progresses faster with any alcohol intake.
- When to seek emergency care: New or worsening confusion, vomiting blood or passing black tarry stools, fever with abdominal pain, rapid weight gain (>2 lbs/day), and inability to take lactulose.
- Driving safety: Patients with covert HE may have impaired reaction time and judgment. Discuss driving risk honestly.
- Follow-up: Regular hepatology appointments, lab monitoring (every 1–3 months depending on severity), and liver transplant evaluation if indicated.
The SBAR communication framework is the standard tool for reporting changes in a liver failure patient’s condition to the provider. For encephalopathy changes specifically, include: current HE grade, last ammonia level, lactulose adherence and stool frequency, and any identified precipitants.
Key takeaways for nursing students
- Liver failure is multisystem — your assessment must be comprehensive, covering neuro, integumentary, GI, renal, and hemodynamic status every shift.
- Hepatic encephalopathy is the complication most responsive to nursing intervention. Know the West Haven grades, identify precipitants early, and titrate lactulose to 2–3 soft stools daily.
- Child-Pugh classifies chronic liver disease severity. MELD drives transplant listing. Know what each score tells you.
- Coagulopathy is always present — monitor INR trends, minimize invasive procedures, and watch for bleeding constantly.
- Medication safety in liver failure requires vigilance. The liver metabolizes most drugs, and standard doses become toxic doses in these patients.
- Acute liver failure and chronic liver failure are different diseases with different trajectories — do not confuse them on NCLEX or in clinical practice.
- Nutrition matters — protein restriction for HE is outdated. Current guidelines recommend 1.2–1.5 g/kg/day of protein to prevent sarcopenia.
- Infection is the silent killer. Fever in a patient with ascites means SBP until proven otherwise.
Related references
- Nursing lab values cheat sheet — essential lab reference including liver function tests, coagulation panels, and metabolic panels
- ABG interpretation — for managing respiratory alkalosis and metabolic acidosis in liver failure
- Electrolyte imbalances reference — hyponatremia, hypokalemia, and other imbalances that precipitate hepatic encephalopathy
- Glasgow Coma Scale — objective neurological scoring for encephalopathy monitoring
- SBAR communication — structured communication framework for reporting changes in patient status
- Pancreatitis nursing — related GI condition often seen alongside liver disease
- AKI nursing — hepatorenal syndrome management overlaps significantly with acute kidney injury nursing
- Heart failure nursing — fluid management principles shared between cardiac and hepatic failure
- Sepsis nursing — infection recognition and management in immunocompromised liver failure patients
- Head-to-toe assessment — systematic assessment approach applicable to the multisystem nature of liver failure